measuregroup/AID1801813

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID316891599_AID1801813_PMID_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID316891600_AID1801813_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID316891596_AID1801813_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID316891601_AID1801813_PMID_VALUE4
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35372
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	Radioligand Dose-Displacement Binding Assays (mu) from US Patent US9175000: \"Buprenorphine analogs\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316891596 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316891600 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316891601 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316891599
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1801813

Total number of triples: 13.